DNA Script
PrivateLast Round
Series C
Jan 4, 2022
Total Funding Raised
$613.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DNA Script is a biotechnology company that develops enzymatic DNA synthesis technology and benchtop DNA printers for the rapid, on-demand production of synthetic nucleic acids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, 3D Printing, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNA Script Comparables
Compare DNA Script with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Telesis Bio | 85% | |
| Evonetix | 83% | |
| Switchback Systems | 78% |
DNA Script Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 4, 2022 | ||||
| Series C | Oct 26, 2021 | ||||
| Grant | Apr 27, 2021 | ||||
| Grant | Mar 2, 2021 | ||||
| Series B | Jul 29, 2020 | ||||
Series B | May 16, 2019 |
Key People
Founding team and executive leadership
DNA Script Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Farallon Capital Management | Series C |
| EQT Life Sciences | Series C, Series B |
| Columbia Threadneedle Investments | Series C |
| Idinvest Partners | Seed, Series B, Series A |
| European Commission | Grant |
| M Ventures | Series C, Series B, Series A |
| Columbia Threadneedle Investments | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 38% MoM, reaching 6K.
- May 3, 2026
Partnering with GE Research for technology and product development.
Recent news
Latest coverage and updates
- receives_financingAug 4, 2026
DNA Script, Inc. received financing of $26M in funding on Aug 4th '26.
- partners_withJul 14, 2026
DNA Script, Inc. partnered with Imperial Life Sciences on Jun 30th '26.
DNA Script Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DNA Script's valuation, stock price, and market status.
Is DNA Script a public or private company?
DNA Script is a private company.
What is the current stock price of DNA Script?
DNA Script is a private company with no public stock price. No recent secondary market data is available.
How much is DNA Script worth (valuation)?
Valuation information for DNA Script is not publicly available.
Can I buy DNA Script stock?
DNA Script shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DNA Script's last funding round?
DNA Script's most recent funding round was Series C on January 4, 2022.
Who are the main investors in DNA Script?
Key investors in DNA Script include Idinvest Partners, Catalio Capital Management, Irving Investors, Casdin Capital, eureKARE.
Will DNA Script IPO soon?
No public IPO plans have been announced for DNA Script.
How can I track DNA Script secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DNA Script's secondary market activity and sign up for updates.